Cargando…
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
The recent increase in the frequency of endometrial cancer has emphasized the need for accurate diagnosis and improved treatment. The current diagnosis is still based on conventional pathological indicators, such as clinical stage, tumor differentiation, invasion depth and vascular invasion. However...
Autores principales: | Banno, Kouji, Nogami, Yuya, Kisu, Iori, Yanokura, Megumi, Umene, Kiyoko, Masuda, Kenta, Kobayashi, Yusuke, Yamagami, Wataru, Susumu, Nobuyuki, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709777/ https://www.ncbi.nlm.nih.gov/pubmed/23743825 http://dx.doi.org/10.3390/ijms140612123 |
Ejemplares similares
-
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013) -
Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013) -
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012) -
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)